Newstral
Article
bizjournals.com on 2021-03-15 23:01
Aiming at HIV treatments that last for months, Gilead aligns with Merck
Related news
- Gilead, Merck pause trial of once-a-week HIV drug combobizjournals.com
- COVID Treatments: Gilead Stock Doesn’t Reflect Optimism About RemdesivirForbes
- Jury: Gilead owes Merck $200M in damages over drug patentsneworleanscitybusiness.com
- Gilead, Merck collaborate to develop long-acting HIV treatmentThe Jerusalem Post (JPost.com)
- SGILEAD SCIENCES LAUNCHES HIV GRANT PROGRAM FOR AUSTRALIA starobserver.com.au
- Trump administration sues Gilead, maker of HIV-prevention drugsbizjournals.com
- Gilead pays startup $123M to develop longer-lasting HIV pillbizjournals.com
- Gilead and Merck Join Forces to Develop Long-Acting HIV Treatmentwsj.com
- BMerck and Gilead Are Joining Forces on a Long-Acting HIV Therapybarrons.com
- HIV vaccine at center potential $785M deal between Gilead, East Bay biotechbizjournals.com
- Gilead asks FDA again to approve twice-a-year HIV-fighting drugbizjournals.com
- CVS and Rite Aid have sued Gilead for allegedly blocking lower-cost generic HIV drugsbizjournals.com
- Gilead gives over 5 percent of profits to Bay Area charities, takes on HIV/AIDS targetsbizjournals.com
- Gilead pays Watertown startup Lyndra $123M to develop longer-lasting HIV pillbizjournals.com
- Pharmacy chains sue Gilead for allegedly blocking lower-cost generic HIV drugsbizjournals.com
- Meet the new Gilead exec in charge of work on an HIV vaccine and morebizjournals.com
- KHuman Immunodeficiency Virus (HIV) Market Will Increase Demand In Forecast By 2026 |Gilead, GlaxoSmithKline, Johnson & Johnson, Merck, AbbVie, etcksusentinel.com
- 'The people that most need this drug can't afford it': HIV advocates target Gilead meeting, but company says they're wrongbizjournals.com
- LBiotechnology Market 2021-2026 Size and Share, Recent Enhancements and Regional Analysis | Key Companies: Johnson & Johnson, Roche, Pfizer, Merck, Sanofi, AstraZeneca, Gilead, CELGENE CORPORATION, …liverpoolstudentmedia.com